A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might look like.
The companies will work together on putting in place technology to facilitate remote monitoring and document review for COVID-19 studies and other research.
A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.
The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
The clinical trial site network company's survey of participants offers information that could shed light on ways to improve recruitment and retention.
The two companies will work together to promote technology for at-home clinical research conducted in trials focused on developing respiratory therapies.
After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.
The pharmaceutical company shares details from an ongoing trial looking into the effectiveness of a pair of drugs on treating triple-negative breast cancer.
The CDMO has landed a grant from the Bill and Melinda Gates Foundation’s COVID-19 Therapeutics Accelerator for clinical research in the sub-Saharan region.
The federal agency continues to aid drug developers, trial teams and the public with advice and actions related to the virus behind the global pandemic.
A comprehensive dive into the contract research organization field offers a glimpse into how the virus has affected firms, and what the future might hold.
A leader from the contract research organization explains how home health personnel, decentralized trial technology and other services can help avoid study interruptions
A leader with the industry association discusses the surging interest in harnessing artificial intelligence to advance various treatments and therapies.
The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.
A leader from the clinical development services firm recommends clinical trials change their tack to avoid costly clinical trial interruptions in the face of the pandemic.
The clinical trial company launched the trial around cytokine storm, an immunological reaction associated with severe virus cases, in 15 business days.
A leader with the patient recruitment specialist talks about the need for clinical trials to balance their important work with what’s important to participants.
The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.
